Latest Asian Markets News

Xenitra Limited’s Q3 sales soared to $8.3 million, a 300% jump over Q2, driven by its Nutritionals division and a strategic $30 million partnership with Rockcheck Group for Danone products. The company also launched new OTC medicines and blockchain tokenised sales channels poised to fuel future growth.

Henderson Far East Income Limited posted a robust 23.3% net asset value total return for the half-year ending February 2026, supported by strong Asian tech and financial sector gains. The trust declared a 6.25p interim dividend and raised £39.1 million through new share issuance, securing a spot in the FTSE 250.

Audeara Ltd has posted its second straight quarter of positive operating cash flow, driven by a record Australian wholesale order and expanding technology licensing deals. The company’s cash balance rose to $1.05 million as it advances global market expansions.

ClearVue Technologies slashed its quarterly cash burn by 52.7%, trimming $6.9 million in annual costs, as it pushes forward with multiple international solar projects and key product certifications.

Xenitra Limited (ASX:XEN) has introduced the OPAL Token and Xen Shop, a blockchain-based digital commerce ecosystem aimed at improving product authentication, customer loyalty, and sales transparency across its Asian FMCG markets.

Xenitra Limited has secured a $30 million AUD sales agreement for Danone products with Rockcheck Group and established its Australian subsidiary as an authorised supplier, marking a major step in its China market strategy.

BCI Minerals confirms the Mardie Salt and Potash Project remains on track for first salt shipment in the second half of 2026, supported by binding offtake agreements and a positive salt price outlook driven by supply shortfalls in Asia.

Ovanti Limited is reshaping its future with a strategic shift from its BNPL roots to a global financial Super App, exiting legacy US operations to focus on innovation and international expansion.

Osteopore Limited has secured non-exclusive distribution rights for an injectable regenerative bone filler across Southeast Asia, marking a strategic expansion of its orthopaedic product portfolio and opening new revenue channels.

Rhythm Biosciences has inked a pivotal distribution agreement with UK-based Digistain Limited to introduce its geneType™ genetic test portfolio in Southeast Asia, starting with the Philippines. This marks Rhythm’s first commercial foothold in the region, setting the stage for broader expansion.

Wide Open Agriculture has appointed Craig Swan as its new CEO, signaling a strategic push to commercialise its lupin protein technology and expand its footprint in Asia.

Elanor Investors Group reported a $24.5 million net loss for the half year to December 2024, grappling with debt covenant breaches and defaults. The group has struck a $125 million recapitalisation agreement with Rockworth Capital Partners to stabilise its balance sheet and pursue growth.